Catalysis Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-06-2024
- Paid Up Capital ₹ 0.10 M
as on 20-06-2024
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
About Catalysis Pharma
The Corporate was formerly known as Ditx Technology & Solutions Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bolloju Brahmanandam and Bandoju Srinivas serve as directors at the Company.
- CIN/LLPIN
U73100TG2020PTC139770
- Company No.
139770
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Catalysis Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bolloju Brahmanandam  | Director | 31-Jan-2022 | Current |
| Bandoju Srinivas | Director | 22-Feb-2022 | Current |
Financial Performance and Corporate Structure Insights of Catalysis Pharma.
Enhance accessibility to Catalysis Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Catalysis Pharma?
Unlock access to Catalysis Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Osr Infra Projects LlpActive 6 years 6 monthsBolloju Brahmanandam and Bandoju Srinivas are mutual person
Osr Infra Private LimitedActive 14 years 2 monthsBolloju Brahmanandam and Bandoju Srinivas are mutual person
Therapiva Private LimitedActive 7 years 19 daysBolloju Brahmanandam and Bandoju Srinivas are mutual person
Epione Labs Private LimitedActive 12 years 6 monthsBolloju Brahmanandam and Bandoju Srinivas are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Catalysis Pharma?
Unlock and access historical data on people associated with Catalysis Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Catalysis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Catalysis Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
